Last update 08 May 2025
Altacor Ltd.

Altacor Ltd.

Private Company|2005|United Kingdom|
10-50
|

Overview

Basic Info

Introduction
Altacor is a company that specializes in creating ophthalmic products that cater to the requirements of both ophthalmologists and patients. With expertise in drug development, market knowledge, and comprehension of the European regulatory landscape, Altacor has established a range of top-quality, unique prescription medications that raise the bar in the industry. The company's product line includes treatments for dry-eye, glaucoma, glaucoma surgery, and ocular surgery.

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
5
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
ALT-004a
Glaucoma
More
Pending
ALT-020
Eye Infections
More
Pending
ALT-025
Glaucoma
More
Pending
ALT-022
( H1 receptor )
Glaucoma
More
Pending
ALT-005
Secondary infection
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free